Huabang Health said on the interactive platform on May 9 that the company's participating companies are involved in cell therapy and stem cell-related businesses. 1. Hebei Life Origin Biotechnology Co., Ltd. is the builder and operator of a stem cell bank in Hebei Province. Its core business is cell storage business such as neonatal stem cells, adult immune cells, etc., and clinical research and application transformation of stem cell products. 2. Shenzhen Puruijin Biopharmaceutical Co., Ltd. is mainly engaged in the development of innovative drugs for cell and gene therapy. Its product pipeline includes CAR-T and CAR-NK, etc., and the indications cover hematological tumors, solid tumors, autoimmune diseases, etc. 3. Jiangsu Puxin Biomedical Co., Ltd. is mainly engaged in the CDMO business for cell and gene therapy drugs. It has built a dedicated plasmid construction platform for cellular drugs, a production platform for suspended serum-free viruses, and a fully enclosed cell process development platform. It has supported many partners to successfully incubate various drugs such as CAR-T, TCR-T, stem cells, etc.